Moreover, CXCL12 blockade did not affect the development of virus-specific memory CD4+ and CD8+ T cell responses in the blood or lungs when assessed on day 30 after SARS2-N501YMA30 infection (Supplemental Figure 7, E and F). This evidence concerns the gene CXCL12 and infection.